Jury In Sophos Trial Awards FNJN $15 million

By Lisa Thompson Finjan (NASDAQ:FNJN) won its trial against Sophos yesterday and was awarded $ 15 million for the life of the patents. This was at the high end of the range that an expert witness sug...